Cardiac allograft vasculopathy is thought to be triggered by an alloreactive response to the donor coronary vasculature, resulting in smooth muscle cell proliferation and ultimate occlusion of the donor coronary arteries. To determine whether allogeneic lymphocytes are capable of regulating endothelial-derived smooth muscle cell (SMC) growth factors, human aortic endothelial cells (HAECs) were exposed to allogeneic lymphocytes. The HAEC-lymphocyte co-cultures were assessed for (a) lymphocyte proliferation in response to the allogeneic HAECs; (b) release of soluble factors that stimulate human aortic SMC proliferation; and (c) alteration of HAEC mRNA levels for a panel of known SMC growth factors. Co-culture conditioned medium increased SMC proliferation, compared to medium conditioned by HAECs alone. HAECs exposed to allogeneic lymphocytes increased their expression of mRNA for basic fibroblast growth factor, transforming growth factors a and 0, and platelet derived growth factor A and B chains. These results demonstrate that allogeneic lymphocytes are capable of inducing HAECs to increase mRNA levels for several mesenchymal growth factors and to release bioactive products capable of stimulating SMC cell proliferation in vitro. Additionally, the data support the hypothesis that alloreactive lymphocytes can stimulate allogeneic donor endothelial cells to produce growth factors that may contribute to the intimal thickening seen in cardiac allograft vasculopathy. (J. Clin. Invest. 1993. 
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1. Abbreviations used in this paper: CAV, cardiac allograft vasculopathy; EC, endothelial cell; HAEC, human aortic endothelial cell; HASMC, human aortic smooth muscle cell; HBFG, heparin binding growth factor; MNC, mononuclear cell; poly(A)+ RNA, polyadenylated RNA; SI, stimulation index; SMC, smooth muscle cell.
aggressive and obliterative form of coronary artery disease involving the entire length of the coronary tree and can develop in the cardiac allograft over a matter of months following cardiac transplantation (1) . CAV is a proliferative vasculopathy and not solely an arteriopathy, as evidenced by intimal hyperplasia in not only the coronary arteries but also in the great vessels as well as in the major coronary veins (2) . Due to its diffuse nature, CAV is not amenable to traditional therapeutic approaches to coronary artery disease, such as balloon angioplasty or coronary artery bypass grafting. To date, the only therapy that has been successful is retransplantation.
While the pathogenesis of CAV remains unknown, there is substantial evidence to suggest that CAV is immunologically mediated and probably represents a form of chronic rejection. CAV is solely restricted to the allograft ( 1, 3) . It is more common in patients who produce antibodies to HLA antigens (4) . It is associated with cytomegalovirus infection, which may alter alloantigenicity (5, 6) , and it can be reproduced in rodent allograft models but does not occur in isograft models (7) . In addition, histopathologic studies have demonstrated a low grade inflammatory process in the subendothelial layer of patients with CAV at autopsy (8) .
It is clear that peptide growth factors can act to modulate the proliferation rate of mesenchymal cells by acting in either a positive or negative manner (9-1 1 ) and that for optimal proliferation, the concerted action ofmultiple growth factors is generally required (9) . PDGF is a ubiquitous mitogen produced by a number of tissues including endothelium and is a potent smooth muscle cell (SMC) mitogen as well as a chemoattractant ( 12) . These properties, the finding of PDGF transcripts in atherosclerotic plaques ( 13) , and the upregulation of PDGF mRNA in association with hypercholesterolemia ( 14) , have resulted in substantial interest in this mitogen in traditional atherosclerosis.
Another family ofgrowth factors that has been shown to be a positive effector ofvascular smooth muscle cell growth ( 11 ) is the heparin-binding growth factor/fibroblast growth factor (HBGF) family of mitogens. Seven separate genes of the HBGF family have been identified: acidic and basic fibroblast growth factor (aFGF and bFGF), the int-2 locus, kFGF/hst, FGF-5, FGF-6, and KGF (keratinocyte growth factor). It is important to note that endothelial cells (EC), specifically bovine aortic and microvascular EC, are capable of producing members of the HBGF family of growth factors ( 15, 16) . Finally, both the transforming growth factor, type-beta (TGF-3) and type-alpha (TGF-a) are potent stimulators of SMC proliferation ( 11 ) .
The histologic features of CAV, which include an intact endothelial cell layer, a single internal elastic lamina, and the absence ofvascular necrosis ( 1, 3) , suggest that the mechanism of alloimmunologic vascular attack is more likely endothelial activation resulting in the augmented expression of smooth muscle cell growth factors, rather than a frank vasculitic process. To date, however, there is no evidence that endothelial cell activation by allogeneic lymphocytes can ultimately result in a proliferative vasculopathy. Therefore, the following studies were undertaken to determine whether the interaction ofallogeneic lymphocytes and aortic endothelial cells (a) increases the level of endothelial cell mRNA for a panel of growth factors known to induce smooth muscle cell proliferation, and (b) causes the release ofbiologically active smooth muscle cell mitogens.
Methods
Endothelial and smooth muscle cell isolation and culture. Human aortic endothelial cells (HAECs) and human aortic smooth muscle cells (HASMCs) were isolated, cultured, and characterized as previously described ( 17 ) . Briefly, segments of human ascending aorta were obtained during organ donation after consent was obtained for the donation of any and all tissues. HAECs were isolated by incubating the aortic tissue in a solution of0.1% collagenase (CLS/type 1, 152 U/mg; Worthington Biochemical Corp., Freehold, NJ) in RPMI 1640 supplemented with 100 U/ml penicillin, 100 sg/ml streptomycin, 25 mM Hepes, and 24 mM sodium bicarbonate, pH 7.2 (Gibco, Grand Island, NY), at 370C for 1 h. After the incubation, the HAECs were gently swabbed from the luminal surface ofthe aorta. The purity ofthe HAEC cultures was determined by their uniform immunofluorescent staining to Factor VIII-related antigen (A082; Dako Corp. Carpinteria, CA) (17) (18) (19) and their uptake of fluorescent-labeled acetylated LDL (DiIAc-LDL; Biomedical Technologies, Inc., Stoughton, MA) ( 17, 20) . All studies were performed using "pooled HAECs" generated by combining an equal number of cells from each of seven separate HAEC cultures. The pooled HAECs were from donors representing a wide range of HLA antigens (see Table I ). The HAECs were cultured in endothelial growth medium (EGM-UV; Clonetics Corp., San Diego, CA) supplemented with an additional 3% FCS (Tissue Culture Biologicals, Tulare, CA) and were used at passages 7-9 to insure adequate numbers of endothelial cells for the studies below.
HASMCs were isolated from the aortic tissue (after removing HAECs) by an additional 1-h incubation at 37°C in RPMI 1640 containing collagenase (0.2%) and elastase (0.2%, E-0258, 67 U/mg; Sigma Chemical Co. St. Louis, MO), and again swabbing the luminal surface. The identity and purity (> 95%) of the HASMCs were confirmed by staining with the smooth muscle a-actin-specific mAb HHF35 (a generous gift by Dr. Allen Gown, University ofWashington, Seattle, WA) and by a second smooth muscle-specific a-actin mAb (no. 1148818; Boehringer Mannheim Biochemicals, Indianapolis, IN) ( 17, 21, 22) . HASMCs were cultured in RPMI 1640 supplemented with 20% FCS.
Experimental design. In each experiment, pooled HAECs were incubated separately with two lymphocyte isolates. One set of HAEC controls (i.e., HAECs cultured without lymphocytes) served as the control in each experiment for both lymphocyte preparations. In each ofthe experiments, all aspects ofthe study, including lymphocyte proliferation, conditioned medium generation, and HAEC mRNA isolation, were performed together. A total of 5 experiments, using lymphocytes from 10 individuals, were performed for these studies, resulting in 10 individual experimental and 5 control samples.
Lymphocyte isolation. Lymphocytes were isolated from peripheral blood buffy coats as previously described ( 18, 23 Lymphocyte proliferation. On the day that the lymphocytes were isolated (day 0), the 96-well plates containing wells of confluent HAECs were irradiated (2,000 rad, Cs'37) to prevent any further proliferation of the HAECs, the medium was removed from the wells, the wells washed with RPMI 1640, and the lymphocytes added to the wells in the co-culture medium described above. As in the co-cultures above, the lymphocytes were added to give a lymphocyte/HAEC ratio of 10: 1 (3 X I05lymphocytes/well). Controls HAECPoly (A) + RNA isolation. 20 h after the addition oflymphocytes to the HAECs, the lymphocytes were removed from the HAEC monolayers by multiple washings with RPMI 1640 (see above). Visual microscopic evaluation consistently demonstrated less than 0.1% of contaminating lymphocytes relative to the remaining HAECs, after washing. Poly (A)' RNA was isolated from HAECs, using MicroFast Track mRNA Isolation Kits (Invitrogen, San Diego, CA) per the manufacturer's protocol. Briefly, cell monolayers were disrupted, using a SDS-containing lysis buffer. Lysates were subjected to a proteinase K digestion. The DNA was sheared and the poly (A)'-containing RNA was allowed to bind to oligo(dT)-cellulose. The oligo(dT)-cellulose was then washed several times with high salt buffer followed by two low salt washes. After which, bound material was eluted with salt-free elution buffer and precipitated by the addition of 1/7 vol 2 M sodium acetate and 3 vol of 100% ethanol and incubation at -20'C overnight. The concentration of RNA was determined by spectrophotometry. Oligonucleotide primers were designed from the published human cDNA sequences of acidic and basic fibroblast growth factors (aFGF and bFGF, respectively), transforming growth factors alpha and beta (TGF-a and TGF-f,, respectively) and both the A and B chains of PDGF (PDGF A and PDGF B, respectively) (Genbank Accession numbers M23017, J04513, K03222, X02812, X03795, and M16288, respectively) and the published human cDNA sequence ofamphiregulin (AR) (24) and IL-lIa (25) . Primers corresponding to the coding and noncoding strands were synthesized: IL-la 5'GAGCATGGTGGTAGTAGCAA3', 5'CGTGAGGTACTGATCATTGG3';
All primers were designed to cross intron-exon boundaries and were verified to be unique for the genes studied, based on the Genbank data base. Primers were tested with high cycle amplification (at least 40 cycles) and all PCR products produced single bands on agarose gel electrophoresis at the appropriate molecular weights. To confirm further the identity of the amplified cDNA, restriction enzyme analysis was performed. In general, two different endonucleases were used for each diagnosis. In all cases the appropriate fragment sizes were produced for each of the gene products studied. Quantification ofPCR products by HPLC. The PCR products were quantitated using a HPLC system (model 1090; Hewlett Packard Co., Palo Alto, CA) equipped with a UV detector, data handling chemstation, and a TSK DEAE-NPR analytic column (Perkin Elmer Cetus Corp., Norwalk, CT) as previously described (26) with minor modifications. 40 of the 50 ,l of the PCR product were utilized per injection.
The mobile phase consisted of two solvents, 1 M NaCl with 25 mM Tris-HCl (solvent A) and 25 mM Tris-HCl alone (solvent B), adjusted to a pH of 9.0, and filtered (0.22 Mm membrane). HaeIII digested pBR322 DNA (Boehringer Mannheim Biochemicals) was used as a molecular weight marker. The separated PCR-generated cDNA products were analyzed for their absorbance peak ("HPLC area").
The ability to accurately quantitate cDNA PCR products using HPLC was confirmed at several levels in control studies using Poly (A)' RNA from HAECs. Fig. 1 is an example of an HPLC elution profile. The PCR product analyzed in this example was cDNA amplified with primers specific for TGF-a. The abscissa is the elution time and the ordinate is the absorbance at 260 nm of the eluted fractions. HPLC of PCR products resulted in their elution at characteristic time points, in this case 6.34 min.
As the goal for these experiments was to determine whether relative differences in the amounts of mRNA expressed by lymphocyte-co-cultured HAECs and control HAECs existed, no attempt was made to determine absolute numbers of mRNA copies per cell. Therefore, each set of oligo primers was tested individually to insure that a linear relationship existed between the amount of Poly (A)' RNA used in the reverse transcription-PCR sequence and the amount of amplified cDNA detected by chromatography. An example of this verification is demonstrated for bFGF in Fig. 2 . Varying amounts (2 to 40 Ml) ofPCR cDNA from a single PCR were quantified multiple times by HPLC (Fig. 2 A) . There was a linear relationship between the amount of PCR cDNA product injected and the HPLC area. When cDNA product ofa single reverse transcription reaction was titrated over a broad range, each amount of cDNA input into a separate PCR reaction and quantified by HPLC, again there was a linear relationship (Fig. 2 B) . Finally, when Poly (A)' RNA was titrated, each concentration was individually reverse-transcribed, the cDNA products individually amplified by PCR, and the PCR products quantified by HPLC, there was a linear relationship between the initial amount of Poly (A)' RNA and the final amount of cDNA detected by HPLC (Fig. 2 C) .
To insure viability of all steps of each experimental setup, a known quantity of human ,B-globin mRNA (kindly donated by Dr. G. Bagby, Veterans Affairs Medical Center, Portland, OR) was added to each of the HAEC Poly (A)' RNA isolates. This mRNA was then reverse-transcribed and amplified at both cycle numbers used in this protocol with the HAEC poly (A)' RNA and quantitated by HPLC. The HPLC area of fl-globin product amplified at 20 cycles and 30 cycles was 24.9±4.9 and 84.7±21.6, respectively. Since HAECs do not appreciably express human fl-globin mRNA under any of the conditions described above, detection of the f3-globin-specific PCR product for the individual Poly (A)' RNA isolates confirmed the viability of each of the steps of the mRNA isolation and detection.
Syngeneic lymphocyte-HAEC responses. To examine the response using both lymphocytes and HAECs from the same donor (syngeneic Figure 1 . Typical chromatogram produced from HPLC separation of PCR products. The PCR product analyzed in this example was cDNA amplified with primers specific for TGF-a. The abscissa is the elution time and the ordinate is the absorbance at 260 nm of the eluted fractions. HPLC of PCR products resulted in their elution at characteristic time points (6.34 min for TGF-a, arrow). The amount measured is proportional to the integrated area under the peak. response), lymphocytes were isolated from abdominal lymph nodes and HAECs were isolated from thoracic aortas, as described above, from two additional organ donors. Lymphocyte proliferation to syngeneic HAECs after 5 d of co-culture was performed as previously described. Proliferation of the abdominal lymph node lymphocytes to a nonspecific mitogen (PHA, 12.5 gg/ml) was also assessed. HAEC growth factor expression was performed 20 h after co-culture again, as previously described.
Data analysis. Both lymphocyte and HASMC proliferation were expressed as cpm and are a result ofquadruplicate determinations that were averaged. PCR product was expressed as the HPLC area under the cDNA peak. Results from the entire group of HAEC-lymphocyte cocultures or their products (activated HAEC cultures) were compared to the entire group of HAEC cultures alone (control HAEC cultures) or their products, pairing those activated HAEC cultures with their respective control HAEC cultures. Differences were determined using Student's t test for paired data, resulting in a single P value for a given assay (e.g., bFGF mRNA levels). Correlations between measurements were performed using Pearson's correlation coefficient r. Significance was considered present at a P value of < 0.05.
Results
Allogeneic lymphocyte proliferation to HAECs. Antigen presenting cells such as endothelial cells, are known to stimulate the proliferation of lymphocytes when the lymphocytes and stimulating cells are allogeneic (27) . While the MHC phenotype of the pooled HAECs used for these studies was partially known (Table I) , the lymphocytes for the experiments below came from anonymous blood donors whose MHC phenotypes were unknown. To ascertain whether the lymphocytes from the separate donors were alloreactive to the HAECs, a mixed endothelial cell-lymphocyte culture was performed for each lymphocyte donor. Lymphocytes were cultured with the HAECs and lymphocyte proliferation was assayed after 3 and 5 d for the incorporation of [3H]thymidine. While the magnitude varied, the lymphocytes from all 1O donors were alloreactive to the HAECs (Table II) . There was no evidence of lymphocyte proliferation in response to syngeneic HAECs in the two co-cultures studied (SI < 2.0, at 5 d, results not shown), but both isolates responded appropriately to PHA.
HASMC proliferation in response to mixed HAEC-lymphocyte conditioned medium. If the interaction of allogeneic lymphocytes and endothelial cells stimulates endothelial cell production of smooth muscle cell growth factors, then it is possible that those growth factors would be released into the medium of the co-cultured lymphocytes and HAECs. To test this possibility, medium was collected from nine co-cultures of lymphocytes and HAECs (activated-HAEC media), added to wells of 96-well plates containing HASMCs, and assayed for its ability to stimulate HASMC proliferation. Each time activated-HAEC medium was generated, medium was also collected from HAECs cultured alone (control media). Activated-HAEC medium from seven of the nine combinations of lymphocytes and HAECs significantly increased HASMC incorporation of [3H]thymidine, compared to that of HASMCs cultured in control medium (P = 0.014, Fig. 3 Allogeneic lymphocyte regulation ofHAEC-derived growth factor mRNA. There are several mechanisms that could account for the increased HASMC growth stimulatory activity of (Fig. 4) . The relative quantities of mRNA for bFGF, TGF-,3, and PDGF-A chain all increased significantly with exposure to allogeneic lymphocytes (P < 0.05). Although the increase in TGF-a and PDGF-B chain mRNA was marginally significant (P = 0.077 and P = 0.065, respectively), as mentioned above, in the majority of the activated HAEC cultures there was an increase compared to the control HAEC cultures. In contrast to the above mesenchymal growth factors, there was no significant increase in HAEC mRNA coding for IL-1a in response to allogeneic lymphocytes. Finally, in the two syngeneic co-cultures studied there was no increase in mRNA levels coding for bFGF, TGF-3, TGF-a, PDGF-A chain, or PDGF-B chain.
To exclude the possibility that lymphocyte poly (A)' RNA was partially responsible for the increase in growth factor mRNA, the HAECs were washed extensively to remove any lymphocytes before isolating the HAEC poly (A)' RNA (Methods). Secondly, poly (A)' RNA was isolated from the recovered lymphocytes, reverse-transcribed, and amplified with the same growth factor mRNA oligonucleotide primers as used for the HAEC poly (A)' RNA, and that were analyzed by agarose gel electrophoresis. In order to obtain visual bands, the PCR was performed for 40 cycles (rather than the 20 or 30 cycles for HPLC analysis), and the amount oflymphocyte poly (A)+ RNA used in the reverse transcription reaction was 10-fold higher than would be anticipated, based on the visual assessment of 0.1% or less remaining lymphocytes in the HAEC cultures. PCR products from reverse-transcribed control HAEC poly (A)' RNA resulted in bands specific for bFGF, TGF-a, TGF-,3, and PDGF-A and PDGF-B chains (Fig. 5 A) while the lymphocyte poly (A)' RNA resulted in only extremely faint bands for TGF-# and PDGF-B (Fig. 5 B) . It is unlikely that either of these products from lymphocyte poly (A)' RNA would be detectable at the 20-cycle PCR amplification used for the quantitative analysis. Third, two isolates of naive lymphocytes were activated with PMA; poly (A)' RNA was isolated from these lymphocytes, reverse-transcribed, and amplified with the same growth factor mRNA oligonucleotide primers and amplification programs as used for the HAEC poly (A)' RNA; and the PCR products were quantitated using HPLC. No PCR products were detected for any of the genes studied.
In all experiments lymphocyte proliferation increased, in most experiments mRNA for the various growth factors increased (the exception was IL-1 a), and in most experiments conditioned media increased HASMC proliferation. There were no correlations between growth factor mRNA expression, HASMC proliferation, and lymphocyte proliferation.
Discussion
The data presented here demonstrate that allogeneic lymphocytes are capable ofinducing HAECs to increase the expression of mRNA for a panel of growth factors known to modulate smooth muscle cell proliferation ( 11 ) . These data further demonstrate that as a result of this interaction, biologically active products are produced in the culture medium that increase the proliferation of HASMC in culture. While the pathogenesis of cardiac allograft vasculopathy is unknown, for several reasons it is believed to involve an immune response ofthe recipient to the allogeneic donor vasculature ( 1, 3) . For example, the disease process is limited to the allograft; it does not disseminate to encompass the recipient's own vessels. Yet, while an immunological process is thought to be involved, it certainly is not overtly aggressive. Histopathologic analysis reveals a low grade inflammatory process without vascular necrosis (8) . We and others have proposed that allograft endothelial cells provoke an alloreactive immune response, resulting in the production of cytokines that elicit smooth muscle cell migration and proliferation ( 1, 3) . In addition to their alloantigen presenting capabilities, endothelial cells are a rich source of cell growth factors (12, 15, 16) . Increased production of those cytokines may be induced by the interaction of allogeneic lymphocytes and endothelial cells, thereby stimulating the smooth muscle cell neointimal hyperplasia characteristic ofCAV. Our results support this hypothesis by demonstrating that allogeneic lymphocytes and endothelial cells interact to release biologically active products that stimulate HASMC proliferation in vitro, and that allogeneic lymphocyte-HAEC co-culture increases HAEC expression of mRNA for a panel of growth factors known to modulate smooth muscle cell proliferation.
Endothelial cells are known to be capable of producing a wide variety of cytokines, including those associated with immune responses and those traditionally thought ofas fibroblast or smooth muscle cell growth factors. Such cytokines include IL-1, IL-6, PDGF, TGF-a, TGF-P, aFGF, and bFGF (1, 3, 28) . Besides cytokines such as IL-I and IL-6, whose regulated synthesis and release is known to occur as part of an immune response, there is preliminary evidence oflymphocyte products regulating endothelial cell expression of PDGF (29, 30) . For example, TNF-a and IL-I can induce the expression of PDGF (29, 30) . In contrast another activated-lymphocyte product, IFN-y down-regulates the production of PDGF stimulated by TNF-a or IL1- (30) . Second, the ability to find a direct control for the allogeneic response in this human system is difficult. A truly direct syngeneic control would be to use PBLs from the donor, cultured with the donor's HAEC isolate. Unfortunately, due to the clinical circumstances surrounding brain death, the majority ofdonors are massively transfused as a result of their traumatic injury. Hence, the PBLs are usually not their own. We elected to use lymphocytes isolated from abdominal lymph nodes to maximize recovery of donor lymphocytes. Although these isolates were not co-cultured with the random endothelial cell pool, they both responded appropriately to nonspecific mitogen (PHA). Whether these lymphocytes are an appropriate control for PBLs is unclear.
Third, there was no correlation between the magnitude of the lymphocyte proliferative responses and the level of growth factor expression. The lack of significant correlation may be due to a difference in the harvest time points for the two protocols (lymphocyte proliferation was measured at 3 and 5 d, while HAEC mRNA was isolated at 20 h). Another possibility is that the intracellular signals that trigger lymphocyte proliferation do not completely overlap with those that regulate HAEC mRNA expression. For example, potentially the upregulation ofHAEC mRNA expression is a result ofclass I HLA incompatibilities, while lymphocyte proliferation is a result ofboth class I and II HLA differences.
Fourth, we have demonstrated that mRNA for a variety of growth factors known to stimulate smooth muscle cell proliferation are increased as a result ofthe allogeneic response and that media conditioned by this response in fact stimulate smooth muscle cell proliferation. We do not know whether the specific growth factors investigated are in fact responsible singly, in combination, or not at all for the actual HASMC proliferative response demonstrated. Furthermore, it is conceivable that the responsible soluble factor(s) differ, depending on the specific allo-response (from co-culture to co-culture).
Fifth, it was assumed that the mRNA levels measured were all derived from the HAEC population, given the low numbers of contaminating cells, the lack of significant expression of these growth factor genes in lymphocytes removed from these co-cultures, and the lack of expression of these growth factor genes from PMA-activated lymphocytes. We cannot, however, be absolutely sure that the small numbers of lymphocytes specifically adhering to the HAEC pool after the extensive washing were not activated in a more specific or unique way (compared to less specific activation) and were actively expressing a significant amount of the growth factor genes of interest. Likewise, the conditioned medium was a product of both the lymphocytes and HAECs, and it is possible that the medium contained lymphocyte-produced cytokines that effected the HASMC proliferation. This is unlikely, given the absence of a HASMC proliferative effect from medium conditioned by lymphocytes alone or lectin-stimulated lymphocytes, but, again, we cannot rule out the possibility that lymphocytes specifically activated would not produce different cytokines than lymphocytes nonspecifically activated. If our assumptions are wrong in either instance, this may be less important from a pathophysiologic and mechanistic view of CAV, where lymphocytes have been shown to be present in the vessel wall (3) and thus might be more representative of the in vivo cell-cell interactions.
Finally, while the interaction of the lymphocytes and HAECs almost consistently increased the HAECs bFGF, TGFa & j3, and PDGF mRNA levels, the magnitude of the mRNA increase was modest, ranging between 50 to 150%. This is in fact appropriate for how CAV is thought to progress; smooth muscle cell migration and proliferation in CAV is thought to develop chronically over a period of months to years.
The studies presented here do not exclude the potential contribution of humoral immunity to the development of CAV (1, 4) or the contribution of cytokines produced by the lymphocytes and macrophages that infiltrate the vessel walls in CAV (3) . The results of these experiments do suggest that the interaction of circulating alloreactive recipient lymphocytes with donor endothelial cells can stimulate endothelial cell synthesis of smooth muscle cell migratory and proliferative factors that may be sufficient to lead to the development of CAV.
